检索范围:
排序: 展示方式:
Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets
null
《医学前沿(英文)》 2014年 第8卷 第4期 页码 404-418 doi: 10.1007/s11684-014-0379-2
microRNAs (miRNAs) are a class of conserved, short, non-coding RNAs that have important and potent capacities to regulate gene expression at the posttranscriptional level. In the past several years, the aberrant expressions of miRNAs in the cardiovascular system have been widely reported, and the crucial roles of some special miRNAs in heart development and pathophysiology of various cardiovascular diseases have been gradually recognized. Recently, it was discovered that miRNAs are presented in peripheral circulation abundantly and stably. This has raised the possibility of using circulating miRNAs as biomarkers for diseases. Furthermore, some studies demonstrated that circulating miRNAs may serve as novel extracellular communicators of cell-cell communication. These discoveries not only reveal the functions of circulating miRNAs in cardiovascular system but also inform the development of miRNAs therapeutic strategies. In this review, we discuss the potential roles of circulating miRNAs in a variety of cardiovascular diseases from biomarkers to therapeutic targets to clearly understand the roles of circulating miRNAs in cardiovascular system.
关键词: microRNA cardiovascular disease biomarkers therapeutic target
Prevalence of cardiovascular diseases in China
Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD,
《医学前沿(英文)》 2010年 第4卷 第1期 页码 16-20 doi: 10.1007/s11684-010-0007-8
关键词: cardiovascular diseases prevalence China risk factors prevention
Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases
null
《医学前沿(英文)》 2012年 第6卷 第1期 页码 35-40 doi: 10.1007/s11684-012-0171-0
Inflammation is important in the pathogenesis and development of cardiovascular diseases. Recent studies show that vagus nerve stimulation inhibits pro-inflammatory cytokine production through “the cholinergic anti-inflammatory pathway,” more specifically via the α7 nicotinic acetylcholine receptor (α7nAChR). In the current study, the role of the cholinergic anti-inflammatory pathway during septic shock, hypertension, and myocardial infarction is reviewed, and its possible clinical implications in cardiovascular diseases are discussed.
关键词: α7 nicotinic acetylcholine receptor cardiovascular diseases baroreflex sensitivity
张祝琴,刘德培
《中国工程科学》 2017年 第19卷 第2期 页码 112-116 doi: 10.15302/J-SSCAE-2017.02.019
重大慢性非传染性疾病包括心脑血管疾病、癌症、呼吸系统疾病、糖尿病等,其流行给全球居民健康造成了重大威胁。为进一步对慢性病进行有效预防控制,促进健康、推动经济和社会发展,2014年中国工程院立项并开展了“重大慢性非传染性疾病防治的国际对比研究”项目,对国内外慢性病预防控制情况以及可供我们借鉴的经验进行了详细分析。本文从慢性病发病概况入手,分析了各种疾病的预防控制措施,并对不同国家的慢性病预防控制体系进行比较,凝练有益经验和方法,提出了增强我国慢性病预防控制的措施和建议。
中药生物活性成分对糖脂代谢紊乱疾病的治疗作用和机制 Review
张莹, 鞠佳明, 焦磊, 杨宝峰
《工程(英文)》 2023年 第29卷 第10期 页码 73-82 doi: 10.1016/j.eng.2023.03.004
胆固醇和葡萄糖稳态异常在心血管疾病、脑血管疾病、中枢神经系统疾病和癌症等多种疾病的发生发展中起着至关重要的作用。 越来越多的研究表明,体内脂肪堆积过多与2型糖尿病或胰岛素抵抗有关,高胆固醇和高血糖将加重上述疾病的发展进程。因此,稳定患者的血脂和血糖水平是改善心脑血管和中枢神经系统疾病患者症状的主要策略。中药(CHM)在中国已有两千多年的历史,建立了独特的中医理论,积累了丰富的临床经验。此外,中药在国内外广泛应用于心脑血管疾病的治疗和预防,具有防治高脂血症、糖尿病和高血压等疾病的优势。然而,中药在西方国家的使用仍然相当有限,部分原因是对其多种复杂成分的了解不完整,药理机制不确定。本文就中药生物活性成分及其制剂治疗高脂血症和高血糖症的作用、分子机制和临床研究进展进行综述和讨论。
关键词: Chinese herbal medicines Hyperlipidemia Hyperglycemia Cardiovascular and cerebrovascular diseases
Zhonghua Sun
《医学前沿(英文)》 2011年 第5卷 第3期 页码 254-270 doi: 10.1007/s11684-011-0153-7
关键词: cardiovascular disease multislice computed tomography three-dimensional reconstruction diagnosis visualization
Potential functions of esophageal cancer-related gene-4 in the cardiovascular system
Rui Zhou, Yuanshu Liu, Wenjun Huang, Xitong Dang
《医学前沿(英文)》 2019年 第13卷 第6期 页码 639-645 doi: 10.1007/s11684-019-0701-0
关键词: tumor suppressor gene esophageal cancer-related gene-4 cardiovascular disease hypoxia
Laparoscopic treatment of liver diseases in children
Jia Wei, Jiexiong Feng
《医学前沿(英文)》 2011年 第5卷 第4期 页码 388-394 doi: 10.1007/s11684-011-0165-3
IgG N-糖基心血管年龄独立于真实年龄精准表征心血管事件风险 Article
武志远, 郭政, 郑雨露, 王玉涛, 张海平, 潘慧颖, 李志伟, Lois Balmer, 李霞, 陶丽新, 郭秀花, 王嵬
《工程(英文)》 2023年 第26卷 第7期 页码 99-107 doi: 10.1016/j.eng.2022.12.004
亚临床动脉粥样硬化和代谢紊乱是心血管健康的重要风险因素,应用免疫球蛋白G(IgG)N-聚糖模式作为炎症指标表征其发病风险已有研究报道。然而,对于IgG N-糖基谱在心血管疾病(CVD)风险分层中的能力仍然未知。本研究旨在利用IgG N-糖基标志物开发追踪心血管疾病风险的年龄指数。本研究基于横断面调查,从Busselton健康和老龄研究中共招募1465名40~70岁之间的个体。使用机器学习递归特征消除和惩罚回归算法逐步筛选特征糖基,并开发IgG N-糖基化心血管年龄(GlyCage)指数,以反映归因于心血管风险的与真实年龄间的偏差。结果显示,对GlyCage指数贡献最大的是具有双分叉N-乙酰葡萄糖胺(GlcNAc)的岩藻糖基化N-聚糖(GP6, FA2B)和具有双分叉GlcNAc的双半乳糖基化N-聚糖(GP13, A2BG2)。GlyCage独立于真实年龄,与较高的Framingham十年心血管风险[优势比(OR)为1.09;95% CI: 1.05~1.13]和患心血管疾病概率(OR, 1.07; 95% CI: 1.01~1.13)显著相关。GlyCage大于真实年龄三年及以上的个体,其心血管风险和心血管疾病患病概率增加,调整后的OR值分别为2.22(95% CI:1.41~3.53)和2.71(95% CI: 1.25~6.41)。GlyCage指数区分十年心血管风险和事件的ROC曲线下面积(AUC)值分别为0.73和0.65,而真实年龄为0.65和0.63。因此,本研究开发的GlyCage指数利用IgG N-糖基谱追踪心血管健康水平。GlyCage和真实年龄之间的差距能够独立地表征心血管风险,提示IgG N-糖基化在心血管疾病的发病机制中起作用。GlyCage指数对心血管风险的预测能力需要在其他人群中进行外部和纵向验证。
null
《医学前沿(英文)》 2013年 第7卷 第3期 页码 389-394 doi: 10.1007/s11684-013-0281-3
Despite the current acceleration and increasing leadership of Chinese genetics research, genetics and its clinical application have largely been imported to China from the Occident. Neither genetics nor the scientific reductionism underpinning its clinical application is integral to the traditional Chinese worldview. Given that disease concepts and their incumbent diagnoses are historically derived and culturally meaningful, we hypothesize that the cultural expectations of genetic diagnoses and medical genetics practice differ between the Occident and China. Specifically, we suggest that an undiagnosed diseases program in China will differ from the recently established Undiagnosed Diseases Program at the United States National Institutes of Health; a culturally sensitive concept will integrate traditional Chinese understanding of disease with the scientific reductionism of Occidental medicine.
关键词: genetics cultural differences undiagnosed diseases program
Diagnosis and therapy of lacrimal system diseases by micro lacrimal endoscope
Nan XIANG, Weikun HU, Jing YUAN, Guigang LI, Haixia LIU
《医学前沿(英文)》 2009年 第3卷 第1期 页码 113-117 doi: 10.1007/s11684-009-0001-1
Responses to emerging and re-emerging infectious diseases: One world, One health
null
《医学前沿(英文)》 2018年 第12卷 第1期 页码 1-2 doi: 10.1007/s11684-018-0619-y
Therapeutic application of hydrogen sulfide donors: the potential and challenges
null
《医学前沿(英文)》 2016年 第10卷 第1期 页码 18-27 doi: 10.1007/s11684-015-0427-6
Hydrogen sulfide (H2S), a colorless gas smelling of rotten egg, has long been considered a toxic gas and environment hazard. However, evidences show that H2S plays a great role in many physiological and pathological activities, and it exhibits different effects when applied at various doses. In this review, we summarize the chemistry and biomedical applications of H2S-releasing compounds, including inorganic salts, phosphorodithioate derivatives, derivatives of Allium sativum extracts, derivatives of thioaminoacids, and derivatives of anti-inflammatory drugs.
轴向零泊松比结构心血管支架的设计、3D打印与表征 Article
王程锦, 张磊, 方永聪, 孙伟
《工程(英文)》 2021年 第7卷 第7期 页码 979-990 doi: 10.1016/j.eng.2020.02.013
药物洗脱支架固有的缺陷促进了生物可吸收心血管支架的研究与发展。近年来,增材制造技术(也称3D打印技术)在医疗器械领域得到了广泛的应用。本文提出了一种新型的微螺杆挤出式3D打印系统,并利用该系统制备了一种具有零泊松比(ZPR)结构的支架。首先进行了初步的单丝挤出试验来研究合适的制造参数;随后,制备了具有不同几何结构的3D打印支架,并通过扫描电子显微镜(SEM)观察分析支架表面形貌;最后,对不同参数的3D打印支架进行了力学性能评价和初步的生物学评价。总之,基于微螺杆挤出式3D打印系统具有制备个性化支架的潜力。
标题 作者 时间 类型 操作
Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases
null
期刊论文
Multislice computed tomography angiography in the diagnosis of cardiovascular disease: 3D visualizations
Zhonghua Sun
期刊论文
Potential functions of esophageal cancer-related gene-4 in the cardiovascular system
Rui Zhou, Yuanshu Liu, Wenjun Huang, Xitong Dang
期刊论文
IgG N-糖基心血管年龄独立于真实年龄精准表征心血管事件风险
武志远, 郭政, 郑雨露, 王玉涛, 张海平, 潘慧颖, 李志伟, Lois Balmer, 李霞, 陶丽新, 郭秀花, 王嵬
期刊论文
Cultural differences define diagnosis and genomic medicine practice: implications for undiagnosed diseases
null
期刊论文
Diagnosis and therapy of lacrimal system diseases by micro lacrimal endoscope
Nan XIANG, Weikun HU, Jing YUAN, Guigang LI, Haixia LIU
期刊论文